Adalimumab Drug Optimisation in Rheumatoid Arthritis Using Therapeutic Drug Monitoring

Clinical trial NCT04194827 · UNKNOWN

Trial details

NCT number: NCT04194827
Sponsor: Reade Rheumatology Research Institute
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2020-03-01
Primary completion: 2024-12-01
Enrollment: 267

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.